Qualigen Therapeutics, Inc. announced that on July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company?s Board of Directors effective upon the Company?s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024. On July 5, 2024, the Company?s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company?s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024. Board Committee assignments for these three persons have not yet been determined.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3867 USD | -9.97% |
|
+38.16% | -29.69% |
07-15 | Qualigen Therapeutics, Inc. Announces Board Changes | CI |
07-08 | Qualigen Therapeutics, Inc. announced that it has received $2 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-29.69% | 3.72M | |
+22.15% | 46.56B | |
+44.76% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics, Inc. Announces Board Changes